MAPT and Alzheimer disease: Thus, while this makes p-tau markers highly relevant for early detection of AD, disease diagnosis and patient monitoring, it also makes them unsuitable for specifically tracking insoluble tau aggregate pathology in brain—this being of major significance as tangle deposition, unlike Aβ plaques, strongly associates with clinical symptoms and cognitive decline [67, 68].